ClinicalTrials.Veeva

Menu

Early Use of Noninvasive Positive Pressure Ventilation for Intro-pulmonary Acute Lung Injury

B

Beijing Hospital

Status

Completed

Conditions

Acute Lung Injury

Treatments

Procedure: oxygen therapy
Procedure: noninvasive positive pressure ventilation

Study type

Interventional

Funder types

Other

Identifiers

NCT01581229
2012BAI05B00

Details and patient eligibility

About

To assess the safety and efficacy of noninvasive positive pressure ventilation for patients with intro-pulmonary pulmonary acute lung injury and compare this with high-concentration oxygen therapy.

Enrollment

204 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. acute onset;
  2. a clinical presentation of respiratory distress;
  3. arterial oxygen tension/inspired oxygen fraction (PaO2/FIO2) < 300 mmHg but > 200 mmHg while breathing oxygen delivered by a conventional Venturi device at a maximum concentration (50%);
  4. presence of bilateral pulmonary infiltrates on posteroanterior chest radiograph;
  5. no evidence of left heart failure as assessed by echocardiography and/or a pulmonary artery wedge pressure of <18 mm Hg.
  6. the cause of ALI is consider to be intro-pulmonary.

Exclusion criteria

  1. age <18 yrs;
  2. Glasgow Coma Scale < 11;
  3. airway or facial injury;
  4. pneumothorax or pneumomediastinum;
  5. unable to spontaneously clear secretions from the airways;
  6. cardiogenic shock or severe hemodynamic instability (systolic blood pressure <90 mmHg associated with decreased urinary output (<20 mL.h-1) despite fluid repletion and use of vasoactive agents) of other causes;
  7. severe ventricular arrhythmia or unstable myocardial ischemia;
  8. severe organ dysfunction (Sequential Organ Failure Assessment score > 3);
  9. end-stage patients who were expected to survive < 6 months;
  10. severe abdominal distension;
  11. refusal to receive NPPV;
  12. the cause of ALI is consider to be extrapulmonary;
  13. unable to cooperate with NPPV application;
  14. active upper gastrointestinal bleeding.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

204 participants in 2 patient groups

NPPV
Experimental group
Treatment:
Procedure: noninvasive positive pressure ventilation
Control
Active Comparator group
Treatment:
Procedure: oxygen therapy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems